Genomic landscape of acquired resistance to targeted therapies in metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Harrold, Emily
Keane, Fergus
Sinopoli, Jenna Cohen
Diaz, Luis A.
Cercek, Andrea
Yaeger, Rona
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, GME Off, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
190
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer
    Strickler, John H.
    CANCER SCIENCE, 2023, 114 : 1522 - 1522
  • [2] Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer
    Jones, Jeremy C.
    Ciombor, Kristen K.
    Wu, Christina
    Bekaii-Saab, Tanios S.
    Strickler, John
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 654 - 660
  • [3] Acquired resistance to EGFR-targeted therapies in colorectal cancer
    Van Emburgh, Beth O.
    Sartore-Bianchi, Andrea
    Di Nicolantonio, Federica
    Siena, Salvatore
    Bardelli, Alberto
    MOLECULAR ONCOLOGY, 2014, 8 (06) : 1084 - 1094
  • [4] Survival determinants with matched targeted therapies in BRAF mutant metastatic colorectal cancer (mCRC).
    Sanz-Garcia, Enrique
    Martinez, Ana Maria
    Elez, Elena
    Argiles, Guillem
    Grasselli, Julieta
    Macarulla, Teresa
    Capdevila, Jaume
    Alsina, Maria
    Sauri, Tamara
    Hierro, Cinta
    Matos, Ignacio
    Verdaguer, Helena
    Azaro, Analia
    Landolfi, Stefania
    Hernandez-Losa, Javier
    Rodon, Jordi
    Nuciforo, Paolo
    Vivancos, Ana
    Dienstmann, Rodrigo
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Genomic landscape of metastatic colorectal cancer
    Haan, Josien C.
    Labots, Mariette
    Rausch, Christian
    Koopman, Miriam
    Tol, Jolien
    Mekenkamp, Leonie J. M.
    van de Wiel, Mark A.
    Israeli, Danielle
    van Essen, Hendrik F.
    van Grieken, Nicole C. T.
    Voorham, Quirinus J. M.
    Bosch, Linda J. W.
    Qu, Xueping
    Kabbarah, Omar
    Verheul, Henk M. W.
    Nagtegaal, Iris D.
    Punt, Cornelis J. A.
    Ylstra, Bauke
    Meijer, Gerrit A.
    NATURE COMMUNICATIONS, 2014, 5
  • [6] Genomic landscape of metastatic colorectal cancer
    Josien C. Haan
    Mariette Labots
    Christian Rausch
    Miriam Koopman
    Jolien Tol
    Leonie J. M. Mekenkamp
    Mark A. van de Wiel
    Danielle Israeli
    Hendrik F. van Essen
    Nicole C. T. van Grieken
    Quirinus J. M. Voorham
    Linda J. W. Bosch
    Xueping Qu
    Omar Kabbarah
    Henk M. W. Verheul
    Iris D. Nagtegaal
    Cornelis J. A. Punt
    Bauke Ylstra
    Gerrit A. Meijer
    Nature Communications, 5
  • [7] Targeted therapies for metastatic colorectal cancer (mCRC): A systematic review of cost-effectiveness (CE).
    Bentley, Tanya G.
    Broder, Michael Samuel
    Das, Lopamudra
    Ortendahl, Jesse
    Su, Yun
    Wagner, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [8] Mechanisms of acquired resistance to targeted cancer therapies
    Lackner, Mark R.
    Wilson, Timothy R.
    Settleman, Jeff
    FUTURE ONCOLOGY, 2012, 8 (08) : 999 - 1014
  • [9] Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer
    Harrold, Emily
    Keane, Fergus
    Walch, Henry
    Chou, Joanne F.
    Sinopoli, Jenna
    Palladino, Silvia
    Al-Rawi, Duaa H.
    Chadalavada, Kalyani
    Manca, Paolo
    Chalasani, Sree
    Yang, Jessica
    Cercek, Andrea
    Shia, Jinru
    Capanu, Marinela
    Bakhoum, Samuel F.
    Schultz, Nikolaus
    Chatila, Walid K.
    Yaeger, Rona
    CLINICAL CANCER RESEARCH, 2024, 30 (12) : 2672 - 2683
  • [10] An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer
    Mo, Christiana
    Chadha, Bhawneet
    Kuang, Chaoyuan
    CLINICAL COLORECTAL CANCER, 2024, 23 (04) : 337 - 345
12345